Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2024-06-21
Target enrollment:
Participant gender:
Summary
To evaluate efficacy and safety of peri-operative sintilimab in combination with SOX in
resectable locally advanced gastric or gastroesophageal junction adenocarcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital